Zoniporide preserves left ventricular compliance during ventricular fibrillation and minimizes postresuscitation myocardial dysfunction through benefits on energy metabolism

Critical Care Medicine

Volumn 35, Issue 10, 2007, Pages 2329-2336

  Ayoub, Iyad M ^a   Kolarova, Julieta D ^a   Kantola, Ronald L ^a   Radhakrishnan, Jeejabai ^a   Wang, Sufen ^a   Gazmuri, Raúl J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Cardiopulmonary resuscitation; Energy metabolism; Myocardial ischemia; Sodium hydrogen antiporter; Ventricular fibrillation

Indexed keywords

ADENOSINE; CREATINE; CREATINE PHOSPHATE; LACTIC ACID; SODIUM PROTON EXCHANGE PROTEIN 1; ZONIPORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DOMESTIC ANIMAL; DRUG EFFECT; DRUG MECHANISM; ENERGY METABOLISM; EXPERIMENTAL PIG; EXTRACORPOREAL CIRCULATION; HEART INDEX; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RESUSCITATION; TREATMENT OUTCOME;

ANIMALS; ENERGY METABOLISM; GUANIDINES; HEART; MALE; MYOCARDIUM; PYRAZOLES; SWINE; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 34748834084     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000280569.87413.74     Document Type: Article

References (45)

1. 2 production during cardiac arrest and resuscitation. Circulation 1989; 80:684-692
2. Kette F, Weil MH, Gazmuri RJ, et al: Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med 1993; 21:901-906
3. Karmazyn M, Sawyer M, Fliegel L: The na(+)/h(+) exchanger: A target for cardiac therapeutic intervention. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5:323-335
4. Imahashi K, Kusuoka H, Hashimoto K, et al: Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 1999; 84:1401-1406
5. Gazmuri RJ, Hoffner E, Kalcheim J, et al: Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med 2001; 137:43-55
6. Avkiran M, Ibuki C, Shimada Y, et al: Effects of acidic reperfusion on arrhythmias and Na(+)-K(+)-ATPase activity in regionally ischemic rat hearts. Am J Physiol 1996; 270:H957-H964
7. An J, Varadarajan SG, Camara A, et al: Blocking Na(+)/H(+) exchange reduces [Na(+)] (i) and [Ca(2+)] (i) load after ischemia and improves function in intact hearts. Am J Physiol 2001; 281:H2398-H2409
8. Yamamoto S, Matsui K, Ohashi N: Protective effect of Na+/H+ exchange inhibitor, SM-20550, on impaired mitochondrial respiratory function and mitochondrial Ca2+ overload in ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 2002; 39:569-575
9. Borutaite V, Brown GC: Mitochondria in apoptosis of ischemic heart. FEBS Lett 2003; 541:1-5
10. Avkiran M: Protection of the ischaemic myocardium by Na+/H+ exchange inhibitors: potential mechanisms of action. Basic Res Cardiol 2001; 96:306-311
11. Karmazyn M, Sostaric JV, Gan XT: The myocardial Na+/H+ exchanger: A potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 2001; 61:375-389
12. Knight DR, Smith AH, Flynn DM, et al: A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther 2001; 297:254-259
13. Portman MA, Panos AL, Xiao Y, et al: HOE-642 (cariporide) alters pH (i) and diastolic function after ischemia during reperfusion in pig hearts in situ. Am J Physiol Heart Circ Physiol 2001; 280:H830-H834
14. Cox CS Jr, Allen SJ, Sauer H, Laine GA: Improved myocardial function using a Na+/H+ exchanger inhibitor during cardioplegic arrest and cardiopulmonary bypass. Chest 2003; 123:187-194
15. Rabkin DG, Cabreriza SE, Cheema FH, et al: Cariporide is cardioprotective after iatrogenic ventricular fibrillation in the intact swine heart. Ann Thorac Surg 2003; 76:1264-1269
16. Ayoub IM, Kolarova JD, Yi Z, et al: Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 2003; 107:1804-1809
17. Kolarova JD, Ayoub IM, Gazmuri RJ: Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship. Am J Physiol Heart Circ Physiol 2005; 288:H2904-H2911
18. Gazmuri RJ, Ayoub IM, Hoffner E, et al: Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 2001; 104:234-239
19. Kolarova J, Yi Z, Ayoub IM, et al: Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation. Chest 2005; 127:1327-1334
20. 2+ accumulation and attenuates myocardial injury. J Appl Physiol 2007; 103:55-65
21. Downey JM, Chagrasulis RW, Hemphill V: Quantitative study of intramyocardial compression in the fibrillating heart. Am J Physiol 1979; 237:H191-H196
22. Otto CM. Left and Right Ventricular Systolic Function. In: Textbook of Clinical Echocardiography. Philadelphia, Elsevier Saunders, 2004, pp 131-163
23. Kelley KW, Curtis SE, Marzan GT, et al: Body surface area of female swine. J Anim Sci 1973; 36:927-930
24. Parker MM, Ognibene FP, Parrillo JE: Peak systolic pressure/end-systolic volume ratio, a load-independent measure of ventricular function, is reversibly decreased in human septic shock. Crit Care Med 1994; 22:1955-1959
25. Chendrasekhar A, Barringer LS, Fagerli JC, et al: Load-independent left ventricular function in a hemorrhagic shock model. J Surg Res 1996; 62:49-52
26. Allison TB, Ramey CA, Holsinger JW Jr: Effects on labile metabolites of temporal delay in freezing biopsy samples of dog myocardium in liquid nitrogen. Cardiovasc Res 1978; 12:162-166
27. Tomasetti M, Graciotti L, Fulgenzi G, et al: Determination of high-energy phosphate compounds and inorganic phosphate by reversed-phase high-performance liquid chromatography: Evaluation of myocardial metabolic status in aerobically perfused and hypoxic mouse heart. J Chromatogr B Biomed Sci Appl 2001; 751:229-236
28. Noll F: Determination with LDH, GPT and NAD. In: Bergmeyer HU (Ed). Methods of Enzymatic Analysis. New York and London, Academic Press, 1974, pp 1475-1479
29. Guzman-Perez A, Wester RT, Allen MC, et al: Discovery of zoniporide: A potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. Bioorg Med Chem Lett 2001; 11:803-807
30. Ye J, Clark MG, Colquhoun EQ: Creatine phosphate as the preferred early indicator of ischemia in muscular tissues. J Surg Res 1996; 61:227-236
31. Gazmuri RJ, von Planta M, Weil MH, et al: Cardiac effects of carbon dioxide-consuming and carbon dioxide- generating buffers during cardiopulmonary resuscitation. J Am Coll Cardiol 1990; 15:482-490
32. Klouche K, Weil MH, Sun S, et al: Evolution of the stone heart after prolonged cardiac arrest. Chest 2002; 122:1006-1011
33. Takino M, Okada Y: Firm myocardium in cardiopulmonary resuscitation. Resuscitation 1996; 33:101-106
34. Gazmuri RJ, Berkowitz M, Cajigas H: Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med 1999; 27:1542-1550
35. Lowe JE, Jennings RB, Reimer KA: Cardiac rigor mortis in dogs. J Mol Cell Cardiol 1979; 11:1017-1031
36. Ince C, Ashruf JF, Avontuur JA, et al: Heterogeneity of the hypoxic state in rat heart is determined at capillary level. Am J Physiol 1993; 264:H294-H301
37. Kaasik A, Veksler V, Boehm E, et al: Energetic crosstalk between organelles: Architectural integration of energy production and utilization. Circ Res 2001; 89:153-159
38. Ingwall JS: Transgenesis and cardiac energetics: New insights into cardiac metabolism. J Mol Cell Cardiol 2004; 37:613-623
39. Bessman SP, Carpenter CL: The creatine-creatine phosphate energy shuttle. Annu Rev Biochem 1985; 54:831-862
40. Saks V, Dzeja P, Schlattner U, et al: Cardiac system bioenergetics: Metabolic basis of the Frank-Starling law. J Physiol 2006; 571:253-273
41. Quantitative Bioenergetics: The Measurement of Driving Forces. In: Nicholls DG, Ferguson SJ (Eds). Bioenergetics3. London, Academic Press, 2002, pp 31-52
42. Busa WB: Mechanisms and consequences of pH-mediated cell regulation. Annu Rev Physiol 1986; 48:389-402
43. Vandenberg JI, Metcalfe JC, Grace AA: Mechanisms of pHi recovery after global ischemia in the perfused heart. Circ Res 1993; 72:993-1003
44. Lin H, Suleiman MS: Cariporide enhances lactate clearance upon reperfusion but does not alter lactate accumulation during global ischaemia. Pflugers Arch 2003; 447:8-13
45. Kato R, Foex P: Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002; 49:777-791